# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Myasthenia gravis

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 35 results.
TheRapeutic Effect of Different immunosuppressAnts on Non-Thymoma Ocular Myasthenia Gravis: a Real-world Study
Status: Recruiting
Last Changed: Dec 04, 2019
First Received: Dec 02, 2019
Disease(s): Ocular Myasthenia Gravis
Intervention(s): Symptomatic Treatment, Steroids, Immunosuppressive Agents( azathioprine, tacrolimus, Mycophenolate Mofetil)
Locations: Tangdu Hospotal, Xi'an, Shaanxi, China
Influence of Minimally Invasive Thymectomy on the Subsequent Clinical Course of Myasthenia Gravis
Status: Not yet recruiting
Last Changed: Nov 12, 2019
First Received: Nov 12, 2019
Disease(s): Myasthenia Gravis
Intervention(s): thymectomy (robotic-assisted thoracoscopic, minimally-invasive thymectomy), thymectomy by means of median sternotomy (transsternal), no thymectomy (control)
Locations: Department of Surgery Charité University, Berlin-Mitte, Germany
NeuroCure Clinical Research Center (NCRC), Charité University, Berlin, Berlin-Mitte, Germany
Sana Klinikum Lichtenberg, Berlin, Germany
A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis
Status: Recruiting
Last Changed: Mar 30, 2020
First Received: Jun 03, 2019
Disease(s): Myasthenia Gravis
Intervention(s): Rozanolixizumab, Placebo
Locations: Mg0003 50081, Phoenix, Arizona, United States
Mg0003 50082, Scottsdale, Arizona, United States
Mg0003 50072, Los Angeles, California, United States
Mg0003 50092, Orange, California, United States
Mg0003 50097, San Francisco, California, United States
... and 67 other locations.
Variables Predicting Reintubation After Thymectomy in Patients With Myasthenia Gravis
Status: Recruiting
Last Changed: Jul 24, 2018
First Received: Jul 24, 2018
Disease(s): Myasthenia Gravis
Intervention(s): reintubation
Locations: Genglong Liu, Guangzhou, Guangdong, China
The Impact of Myasthenia Gravis in the Real World
Status: Recruiting
Last Changed: Dec 20, 2019
First Received: Nov 25, 2019
Disease(s): Myasthenia Gravis
Locations: Vitaccess Ltd, Oxford, United Kingdom
An Extension Study of MOM-M281-004 to Evaluate the Safety, Tolerability, and Efficacy of M281 Administered to Patients With Generalized Myasthenia Gravis
Status: Recruiting
Last Changed: Mar 10, 2020
First Received: Mar 29, 2019
Disease(s): Generalized Myasthenia Gravis
Intervention(s): M281
Locations: Momenta Investigational Site, Phoenix, Arizona, United States
Momenta Investigational Site, Los Angeles, California, United States
Momenta Investigational Site, Orange, California, United States
Momenta Investigational Site, Stanford, California, United States
Momenta Investigational Site, Aurora, Colorado, United States
... and 50 other locations.
The EXPLORE MG Registry for Myasthenia Gravis
Status: Recruiting
Last Changed: Sep 25, 2019
First Received: Jan 03, 2019
Disease(s): Myasthenia Gravis
Intervention(s): Blood Sample Draw
Locations: Yale-New Haven Hospital, New Haven, Connecticut, United States
Beta-agonist Efficacy and Tolerability as Adjuvant Therapy in Myasthenia Gravis
Status: Recruiting
Last Changed: Apr 06, 2020
First Received: Apr 16, 2019
Disease(s): Myasthenia Gravis
Intervention(s): Salbutamol 4Mg Tablet, Placebo oral capsule
Locations: Department of Neurology, Aalborg University Hospital, Aalborg, Denmark
Neurology, Aarhus University Hospital, Aarhus, Denmark
A Phase II Study of Pyridostigmine With Ondansetron in Subjects With Anti-AchR Positive Myasthenia Gravis
Status: Not yet recruiting
Last Changed: Jan 13, 2020
First Received: Jan 13, 2020
Disease(s): Myasthenia Gravis
Intervention(s): DAS-001
Locations: George Washinton University, Washington, District of Columbia, United States
A Study of RVT-1401 in Myasthenia Gravis (MG) Patients
Status: Recruiting
Last Changed: Feb 17, 2020
First Received: Mar 05, 2019
Disease(s): Myasthenia Gravis
Intervention(s): RVT-1401, Placebo
Locations: IMC/Diagnostic and Medical Clinic, Mobile, Alabama, United States
Phoenix Neurological Associates, Phoenix, Arizona, United States
The Neurology Center of Southern California, Carlsbad, California, United States
UC Irvine - MDA ALS and Neuromuscular Center, Orange, California, United States
Care Access Research, Pasadena, California, United States
... and 16 other locations.